Cargando…
Multiplicity adjustments in parallel-group multi-arm trials sharing a control group: Clear guidance is needed
Multi-arm, parallel-group clinical trials are an efficient way of testing several new treatments, treatment regimens or doses. However, guidance on the requirement for statistical adjustment to control for multiple comparisons (type I error) using a shared control group is unclear. We argue, based o...
Autores principales: | Molloy, Síle F., White, Ian R., Nunn, Andrew J., Hayes, Richard, Wang, Duolao, Harrison, Thomas S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844584/ https://www.ncbi.nlm.nih.gov/pubmed/34906747 http://dx.doi.org/10.1016/j.cct.2021.106656 |
Ejemplares similares
-
Statistical guidance for responsible data sharing: an overview
por: Fletcher, Christine, et al.
Publicado: (2016) -
The impact of selection bias in randomized multi-arm parallel group clinical trials
por: Uschner, Diane, et al.
Publicado: (2018) -
Need for Risk Adjustment in Adapting Episode Grouping Software to Medicare Data
por: MaCurdy, Thomas, et al.
Publicado: (2009) -
Need to improve availability of “access” group antibiotics and reduce the use of “watch” group antibiotics in India for optimum use of antibiotics to contain antimicrobial resistance
por: Gandra, Sumanth, et al.
Publicado: (2019) -
Group-owned shares
por: de Jong, Michiel
Publicado: (2022)